Find out how immunotherapy can improve cancer treatment outcomes and the systemic barriers limiting its widespread use.
Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...
Despite the introduction of vaccines, the coronavirus disease 2019 (COVID-19) remains a significant problem around the world, particularly for people with weakened immune systems and those who have ...
Credit: Celltrion CRS is a life-threatening condition that results in the excessive release of cytokines into the bloodstream, causing inflammation and damage to organs and tissues. With the newly ...
For patients with lymphoma or multiple myeloma, speaking up about symptoms of cytokine release syndrome can be lifesaving. It’s important for patients receiving bispecific antibodies for lymphoma or ...
As CAR T-cell therapy becomes more common in oncology, predicting the patients who may experience the life-threatening complication called cytokine release syndrome (CRS) is becoming more important.
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial. This is an ASCO Meeting ...
The transition from preclinical development to clinical trials is a critical, yet high-risk stage in drug development, with approximately 89% of drugs failing to progress through all phases of ...
Cytokine release syndrome can limit aggressive RRMM treatment strategies. Jeffrey Matous, MD: We’re going to talk about hurdles giving these treatments. First, let’s talk about the timing of CRS ...
With the newly approved indication for CRS, Avtozma IV now aligns with all approved indications for Actemra IV. CRS is a life-threatening condition in which an overactive immune response leads to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results